Evaluation of BTV100 in Subjects With Dry Eye Disease

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Dry Eye

In brief

This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).

Key facts

Study ID
NCT06543303
Run by
BioTheraVision, Inc.
People needed
120
Starts
2024-12-31
Expected to finish
2026-02-15
Last updated by the study team
2025-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.